Prevalence and dynamics of the K65R drug resistance mutation in HIV‑1‑infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk - AIGHD

07 Apr Prevalence and dynamics of the K65R drug resistance mutation in HIV‑1‑infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk

Posted at 14:18h in by AIGHD

Authored by: Inzaule Seth C., Weidle Paul J., Yang Chunfu, Ndiege Kenneth, Hamers Raph L., Rinke de Wit Tobias F., Thomas Timothy, Zeh Clement
In: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [aheadofprint], 2016, p.‑.
http://jac.oxfordjournals.org/content/early/2016/03/06/jac.dkw039.abstract